Cephalon were obvously informed of the results of the phase iia trial before the bid. This way they still had time to promote their 'huge premium' case.
Arana's new CEO hasn't even bothered to respond to the market but the special dividend says he also approves of this very low offer (which is not special at all because it is being deducted from the offer).
At least the offer has established a rock bottom valuation for the company.
AAH
arana therapeutics limited
Cephalon were obvously informed of the results of the phase iia...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)